ESOPHAGOGASTRIC ADENOCARCINOMA

Clinical trials for ESOPHAGOGASTRIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGOGASTRIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ESOPHAGOGASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug cocktail shows promise for aggressive stomach cancer before surgery

Disease control Ongoing

This study tests if combining trastuzumab-deruxtecan with other drugs before surgery is safe and works for people with HER2-positive stomach cancer that can be removed. About 36 adults with advanced but resectable cancer will receive the treatment. The goal is to see how many can…

Matched conditions: ESOPHAGOGASTRIC ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated May 22, 2026 13:50 UTC

ESOPHAGOGASTRIC ADENOCARCINOMA

Get alerted when new ESOPHAGOGASTRIC ADENOCARCINOMA trials appear

New drug cocktail shows promise for aggressive stomach cancer before surgery